Skip to Main Content

Author Details

Mark T Heise
University of North Carolina at Chapel Hill.
1990
144
49
PMIDPaper TitleJournal TitlePublished Year
36273826COVID-19 Vaccines and the Virus: Impact on Drug Metabolism and Pharmacokinetics.Drug Metab Dispos2023
36273826COVID-19 Vaccines and the Virus: Impact on Drug Metabolism and Pharmacokinetics.Drug Metab Dispos2023
37949067The RNA helicase DDX39A binds a conserved structure in chikungunya virus RNA to control infection.Mol Cell2023
38019013Cryptic-site-specific antibodies to the SARS-CoV-2 receptor binding domain can retain functional binding affinity to spike variants.J Virol2023
37556555Core mitochondrial genes are down-regulated during SARS-CoV-2 infection of rodent and human hosts.Sci Transl Med2023
37961507Adjuvant-dependent effects on the safety and efficacy of inactivated SARS-CoV-2 vaccines during heterologous infection by a SARS-related coronavirus.Res Sq2023
36812267Human ACE2 expression, a major tropism determinant for SARS-CoV-2, is regulated by upstream and intragenic elements.PLoS Pathog2023
36700653Virology under the Microscope-a Call for Rational Discourse.mSphere2023
36700642Virology under the Microscope-a Call for Rational Discourse.mBio2023
36700640Virology under the Microscope-a Call for Rational Discourse.J Virol2023
36563691An epithelial-immune circuit amplifies inflammasome and IL-6 responses to SARS-CoV-2.Cell Host Microbe2023
37000623Fc-mediated pan-sarbecovirus protection after alphavirus vector vaccination.Cell Rep2023
37310228Neuroinvasive Flavivirus Pathogenesis Is Restricted by Host Genetic Factors in Collaborative Cross Mice, Independently of <i>Oas1b</i>.J Virol2023
37243143Effect of Viral Strain and Host Age on Clinical Disease and Viral Replication in Immunocompetent Mouse Models of Chikungunya Encephalomyelitis.Viruses2023
38019013Cryptic-site-specific antibodies to the SARS-CoV-2 receptor binding domain can retain functional binding affinity to spike variants.J Virol2023
37961507Adjuvant-dependent effects on the safety and efficacy of inactivated SARS-CoV-2 vaccines during heterologous infection by a SARS-related coronavirus.Res Sq2023
37556555Core mitochondrial genes are down-regulated during SARS-CoV-2 infection of rodent and human hosts.Sci Transl Med2023
37949067The RNA helicase DDX39A binds a conserved structure in chikungunya virus RNA to control infection.Mol Cell2023
37310228Neuroinvasive Flavivirus Pathogenesis Is Restricted by Host Genetic Factors in Collaborative Cross Mice, Independently of <i>Oas1b</i>.J Virol2023
37243143Effect of Viral Strain and Host Age on Clinical Disease and Viral Replication in Immunocompetent Mouse Models of Chikungunya Encephalomyelitis.Viruses2023
37000623Fc-mediated pan-sarbecovirus protection after alphavirus vector vaccination.Cell Rep2023
36812267Human ACE2 expression, a major tropism determinant for SARS-CoV-2, is regulated by upstream and intragenic elements.PLoS Pathog2023
36563691An epithelial-immune circuit amplifies inflammasome and IL-6 responses to SARS-CoV-2.Cell Host Microbe2023
36700653Virology under the Microscope-a Call for Rational Discourse.mSphere2023
36700642Virology under the Microscope-a Call for Rational Discourse.mBio2023
36700640Virology under the Microscope-a Call for Rational Discourse.J Virol2023
35018375Host kinase CSNK2 is a target for inhibition of pathogenic β-coronaviruses including SARS-CoV-2.bioRxiv2022
36111834Identification and Utilization of a Chemical Probe to Interrogate the Roles of PIKfyve in the Lifecycle of β-Coronaviruses.J Med Chem2022
35526106Nanoformulated Remdesivir with Extremely Low Content of Poly(2-oxazoline)-Based Stabilizer for Aerosol Treatment of COVID-19.Macromol Biosci2022
35834486Genetic diversity of collaborative cross mice enables identification of novel rift valley fever virus encephalitis model.PLoS Pathog2022
35677067A Multitrait Locus Regulates Sarbecovirus Pathogenesis.bioRxiv2022
35862771A Multitrait Locus Regulates Sarbecovirus Pathogenesis.mBio2022
35723434Host Kinase CSNK2 is a Target for Inhibition of Pathogenic SARS-like β-Coronaviruses.ACS Chem Biol2022
36482964Fc mediated pan-sarbecovirus protection after alphavirus vector vaccination.bioRxiv2022
35233572TARGETED DOWN REGULATION OF CORE MITOCHONDRIAL GENES DURING SARS-COV-2 INFECTION.bioRxiv2022
35018375Host kinase CSNK2 is a target for inhibition of pathogenic β-coronaviruses including SARS-CoV-2.bioRxiv2022
35107034Woodsmoke particle exposure prior to SARS-CoV-2 infection alters antiviral response gene expression in human nasal epithelial cells in a sex-dependent manner.Am J Physiol Lung Cell Mol Physiol2022
35677067A Multitrait Locus Regulates Sarbecovirus Pathogenesis.bioRxiv2022
35834486Genetic diversity of collaborative cross mice enables identification of novel rift valley fever virus encephalitis model.PLoS Pathog2022
35723434Host Kinase CSNK2 is a Target for Inhibition of Pathogenic SARS-like β-Coronaviruses.ACS Chem Biol2022
35526106Nanoformulated Remdesivir with Extremely Low Content of Poly(2-oxazoline)-Based Stabilizer for Aerosol Treatment of COVID-19.Macromol Biosci2022
35862771A Multitrait Locus Regulates Sarbecovirus Pathogenesis.mBio2022
36482964Fc mediated pan-sarbecovirus protection after alphavirus vector vaccination.bioRxiv2022
36111834Identification and Utilization of a Chemical Probe to Interrogate the Roles of PIKfyve in the Lifecycle of β-Coronaviruses.J Med Chem2022
35233572TARGETED DOWN REGULATION OF CORE MITOCHONDRIAL GENES DURING SARS-COV-2 INFECTION.bioRxiv2022
35107034Woodsmoke particle exposure prior to SARS-CoV-2 infection alters antiviral response gene expression in human nasal epithelial cells in a sex-dependent manner.Am J Physiol Lung Cell Mol Physiol2022
33411764Novel modulators of p53-signaling encoded by unknown genes of emerging viruses.PLoS Pathog2021
34127050Landscape and selection of vaccine epitopes in SARS-CoV-2.Genome Med2021
34013261Common Mechanism of SARS-CoV and SARS-CoV-2 Pathogenesis across Species.bioRxiv2021
33961695β-d-N4-hydroxycytidine Inhibits SARS-CoV-2 Through Lethal Mutagenesis But Is Also Mutagenic To Mammalian Cells.J Infect Dis2021
  • 1 - 50 of 288

Recommended Authors

James Logue
Center for Pathogen Research, University of Maryland School of Medicine
Career Start Year 2017
Number of shared co-authors 8
Veronica V Rezelj
Quantitative Biosciences Institute (QBI) Coronavirus Research Group (QCRG)
Career Start Year 2015
Number of shared co-authors 7
Erik Van Dis
University of California berkeley
Career Start Year 2014
Number of shared co-authors 3
Chengjin Ye
Texas Biomedical Research Institute
Career Start Year 2013
Number of shared co-authors 4
David Sachs
Icahn School of Medicine at Mount Sinai
Career Start Year 2013
Number of shared co-authors 9
Hongjie Xia
University of Texas Medical Branch
Career Start Year 2012
Number of shared co-authors 3
Shashank Tripathi
Indian Institute of Science
Career Start Year 2011
Number of shared co-authors 13
James Zengel
Stanford University School of Medicine
Career Start Year 2010
Number of shared co-authors 3
Craig B Wilen
Yale School of Medicine
Career Start Year 2010
Number of shared co-authors 9
Carles Mart??nez-Romero
Icahn School of Medicine at Mount Sinai
Career Start Year 2009
Number of shared co-authors 5
Lisa Miorin
Icahn School of Medicine at Mount Sinai
Career Start Year 2008
Number of shared co-authors 10
Alexander N Freiberg
University of Texas Medical Branch
Career Start Year 2008
Number of shared co-authors 9
Hans-Heinrich Hoffmann
The Rockefeller University
Career Start Year 2008
Number of shared co-authors 7
Kristin L McNally
National Institute of Allergy and Infectious Diseases
Career Start Year 2008
Number of shared co-authors 7
Colm Atkins
Rutgers University
Career Start Year 2007
Number of shared co-authors 2
Preeti Bharaj
University of Texas Medical Branch
Career Start Year 2007
Number of shared co-authors 2
Amber M Smith
University of California san francisco
Career Start Year 2006
Number of shared co-authors 4
Jean Chang
Center for Innate Immunity and Immune Disease, University of Washington
Career Start Year 2005
Number of shared co-authors 33
Shannan L Rossi
Institute for Human Infection and Immunity, University of Texas Medical Branch
Career Start Year 2005
Number of shared co-authors 5
Emmie de Wit
National Institute of Allergy and Infectious Diseases, National Institutes of Health
Career Start Year 2004
Number of shared co-authors 14
Kimberly Meade-White
National Institutes of Allergy and Infectious Disease, National Institutes of Health
Career Start Year 2002
Number of shared co-authors 5
Luis Martinez-Sobrido
Texas Biomedical Research Institute
Career Start Year 2001
Number of shared co-authors 16
Gary P Kobinger
University of Texas Medical Branch
Career Start Year 1997
Number of shared co-authors 14
Pei-Yong Shi
University of Texas Medical Branch
Career Start Year 1996
Number of shared co-authors 17
Christopher F Basler
Icahn School of Medicine at Mount Sinai
Career Start Year 1996
Number of shared co-authors 18
Shelly J Robertson
National Institute of Allergy and Infectious Diseases
Career Start Year 1995
Number of shared co-authors 8
Ignacio Mena
Icahn School of Medicine at Mount Sinai
Career Start Year 1994
Number of shared co-authors 10
Lucy Thorne
University College London
Career Start Year 1992
Number of shared co-authors 2
Akiko Iwasaki
Yale University
Career Start Year 1990
Number of shared co-authors 9
Robert F Garry
Tulane University School of Medicine
Career Start Year 1974
Number of shared co-authors 9

Collaborators

Ralph S Baric
University of North Carolina
Co-authored papers 52
Martin T Ferris
University of North Carolina.
Co-authored papers 30
Thomas E Morrison
University of Colorado Anschutz Medical Campus
Co-authored papers 28
Alan C Whitmore
University of North Carolina at Chapel Hill
Co-authored papers 25
Lisa E Gralinski
University of North Carolina at Chapel Hill
Co-authored papers 19
Fernando Pardo-Manuel de Villena
University of North Carolina
Co-authored papers 17
Boyd L Yount
University of North Carolina at Chapel Hill
Co-authored papers 13
Darla R Miller
The University of North Carolina at Chapel Hill
Co-authored papers 12
Matthew B Frieman
Center for Pathogen Research, University of Maryland School of Medicine
Co-authored papers 12
Stephanie A Montgomery
and Lineberger Comprehensive Cancer Center, University of North Carolina System
Co-authored papers 12
Sarah R Leist
University of North Carolina at Chapel Hill
Co-authored papers 12
Alexandra Sch??fer
University of North Carolina at Chapel Hill
Co-authored papers 11
Michael G Katze
University of Washington
Co-authored papers 9
Vineet D Menachery
University of Texas Medical Branch
Co-authored papers 9
Daniel N Streblow
Vaccine and Gene Therapy Institute, Oregon Health and Science University
Co-authored papers 8
Kenneth S Plante
University of Texas Medical Branch
Co-authored papers 8
Clayton R Morrison
University of North Carolina School of Medicine
Co-authored papers 8
Shannon K McWeeney
Oregon Health & Science University, University of California Berkeley
Co-authored papers 7
Mehul S Suthar
Co-authored papers 7
Richard Green
Center for Innate Immunity and Immune Disease, University of Washington
Co-authored papers 7
Victor R DeFilippis
Vaccine and Gene Therapy Institute, Oregon Health and Science University
Co-authored papers 7
David W Threadgill
College Station
Co-authored papers 6
Sudhakar Agnihothram
National Center for Toxicological Research
Co-authored papers 6
Ginger D Shaw
University of North Carolina
Co-authored papers 6
Jennifer M Lund
Fred Hutchinson Cancer Research Center
Co-authored papers 6
Rachel L Graham
University of North Carolina
Co-authored papers 6
Timothy A Bell
University of North Carolina
Co-authored papers 6
Ande West
University of North Carolina at Chapel Hill
Co-authored papers 5
Bronwyn M Gunn
Co-authored papers 5
Michael A Mooney
Knight Cancer Institute Oregon Health & Science University Portland Oregon USA.
Co-authored papers 5
Release 1.2